CHTRX vs. VAFAX

Last updated Jun 3, 2026

CHTRX (Invesco Charter Fund) and VAFAX (Invesco American Franchise Fund Class A) are both mutual funds - CHTRX is a Large Cap Blend Equities fund managed by Invesco, while VAFAX is a Large Cap Growth Equities fund managed by Invesco. Over the past 10 years, CHTRX returned 11.40%/yr vs 15.82%/yr for VAFAX. Their correlation of 0.89 suggests significant overlap in exposure. CHTRX charges 1.03%/yr vs 0.95%/yr for VAFAX.

Performance

CHTRX vs. VAFAX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Invesco Charter Fund (CHTRX) and Invesco American Franchise Fund Class A (VAFAX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CHTRX achieves a 6.37% return, which is significantly lower than VAFAX's 8.55% return. Over the past 10 years, CHTRX has underperformed VAFAX with an annualized return of 11.40%, while VAFAX has yielded a comparatively higher 15.82% annualized return.

CHTRX

• 1D: -0.22%
• 1M: 3.13%
• YTD: 6.37%
• 6M: 6.63%
• 1Y: 21.44%
• 3Y*: 18.98%
• 5Y*: 10.89%
• 10Y*: 11.40%

VAFAX

• 1D: 0.52%
• 1M: 5.21%
• YTD: 8.55%
• 6M: 7.80%
• 1Y: 22.63%
• 3Y*: 22.88%
• 5Y*: 10.49%
• 10Y*: 15.82%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CHTRX vs. VAFAX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CHTRX Invesco Charter Fund	6.37%	16.02%	25.31%	23.03%	-20.75%	27.21%	13.53%	27.95%	-9.82%	13.24%
VAFAX Invesco American Franchise Fund Class A	8.55%	11.86%	34.78%	40.91%	-31.20%	11.13%	42.15%	36.55%	-3.99%	27.11%

Correlation

The correlation between CHTRX and VAFAX is 0.90, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.90
Correlation (3Y) Calculated over the trailing 3-year period	0.90
Correlation (5Y) Calculated over the trailing 5-year period	0.92
Correlation (10Y) Calculated over the trailing 10-year period	0.90
Correlation (All Time) Calculated using the full available price history since Jun 27, 2005	0.89

The correlation between CHTRX and VAFAX has been stable across timeframes, ranging from 0.89 to 0.92 - a consistent structural relationship.

Return for Risk

CHTRX vs. VAFAX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CHTRX

CHTRX Risk / Return Rank: 38
CHTRX Sharpe Ratio Rank: 40
CHTRX Sortino Ratio Rank: 39
CHTRX Omega Ratio Rank: 39
CHTRX Calmar Ratio Rank: 30
CHTRX Martin Ratio Rank: 41

VAFAX

VAFAX Risk / Return Rank: 15
VAFAX Sharpe Ratio Rank: 18
VAFAX Sortino Ratio Rank: 16
VAFAX Omega Ratio Rank: 17
VAFAX Calmar Ratio Rank: 12
VAFAX Martin Ratio Rank: 12

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CHTRX vs. VAFAX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Invesco Charter Fund (CHTRX) and Invesco American Franchise Fund Class A (VAFAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CHTRX	VAFAX	Difference
Sharpe ratio Return per unit of total volatility	1.85	1.24	+0.61
Sortino ratio Return per unit of downside risk	2.61	1.73	+0.89
Omega ratio Gain probability vs. loss probability	1.34	1.22	+0.11
Calmar ratio Return relative to maximum drawdown	2.09	1.23	+0.86
Martin ratio Return relative to average drawdown	8.95	3.73	+5.22
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CHTRX vs. VAFAX - Sharpe Ratio Comparison

The current CHTRX Sharpe Ratio is 1.85, which is higher than the VAFAX Sharpe Ratio of 1.24. The chart below compares the historical Sharpe Ratios of CHTRX and VAFAX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	CHTRX	VAFAX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.85	1.24	+0.61
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.65	0.46	+0.20
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.60	0.71	-0.12
Sharpe Ratio (All Time) Calculated using the full available price history	0.42	0.57	-0.15

Drawdowns

CHTRX vs. VAFAX - Drawdown Comparison

The maximum CHTRX drawdown since its inception was -56.30%, which is greater than VAFAX's maximum drawdown of -48.48%. Use the drawdown chart below to compare losses from any high point for CHTRX and VAFAX.

Drawdown Indicators

	CHTRX	VAFAX	Difference
Max Drawdown Largest peak-to-trough decline	-56.30%	-48.48%	-7.82%
Max Drawdown (1Y) Largest decline over 1 year	-10.77%	-19.27%	+8.50%
Max Drawdown (3Y) Largest decline over 3 years	-18.50%	-27.24%	+8.74%
Max Drawdown (5Y) Largest decline over 5 years	-26.77%	-38.86%	+12.09%
Max Drawdown (10Y) Largest decline over 10 years	-41.18%	-38.86%	-2.32%
Current Drawdown Current decline from peak	-0.48%	-0.54%	+0.06%
Average Drawdown Average peak-to-trough decline	-13.28%	-8.13%	-5.15%
Ulcer Index Depth and duration of drawdowns from previous peaks	2.51%	6.35%	-3.84%

Volatility

CHTRX vs. VAFAX - Volatility Comparison

The current volatility for Invesco Charter Fund (CHTRX) is 3.14%, while Invesco American Franchise Fund Class A (VAFAX) has a volatility of 4.91%. This indicates that CHTRX experiences smaller price fluctuations and is considered to be less risky than VAFAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CHTRX	VAFAX	Difference
Volatility (1M) Calculated over the trailing 1-month period	3.14%	4.91%	-1.77%
Volatility (6M) Calculated over the trailing 6-month period	9.22%	14.65%	-5.43%
Volatility (1Y) Calculated over the trailing 1-year period	12.06%	19.23%	-7.17%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	16.77%	23.05%	-6.28%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	19.18%	22.31%	-3.13%

CHTRX vs. VAFAX - Expense Ratio Comparison

CHTRX has a 1.03% expense ratio, which is higher than VAFAX's 0.95% expense ratio.

Dividends

CHTRX vs. VAFAX - Dividend Comparison

CHTRX's dividend yield for the trailing twelve months is around 6.79%, less than VAFAX's 12.98% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CHTRX Invesco Charter Fund	6.79%	7.22%	7.91%	6.24%	4.25%	16.30%	2.35%	17.60%	11.71%	6.92%	10.39%	14.54%
VAFAX Invesco American Franchise Fund Class A	12.98%	14.09%	3.74%	0.00%	8.32%	26.50%	8.78%	6.85%	10.42%	5.37%	4.08%	4.90%

Frequently Asked Questions

Can I hold both CHTRX and VAFAX in my portfolio?

CHTRX and VAFAX have a correlation of 0.90, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CHTRX or VAFAX?

VAFAX has higher volatility (4.91%) compared to CHTRX (3.14%). In terms of maximum drawdown, CHTRX dropped -56.30% vs VAFAX's -48.48%.

Which has better risk-adjusted returns?

CHTRX currently has the higher Sharpe Ratio (1.85 vs 1.24), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.